Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7492 p273
8 March 2008

This article
Reprint   Photocopy

PDF 50K, Acrobat Reader

Letters

• Darzi review
• Glaucoma
• Minor ailment scheme
• Community pharmacy (2)
• Clinical trials
• Hospital pharmacy


Letters to the Editor

Darzi review

There may be light at the end of the tunnel

From Mr G. S. Phillips, MRPharmS

Pharmacists have been, justifiably, critical of Government health policy, and the Royal Pharmaceutical Society’s own research shows that members want much more effective representation of their professional interests.

The “Darzi Day” held at the Society’s headquarters in Lambeth last week was a useful step in the right direction, which has made me reflect on just how far pharmacy has come: Lord Darzi, a senior Government minister, was prepared to engage with us and listen to our views.

A reasonably representative grassroots group of pharmacists spent most of the day in friendly discussion and open debate with Keith Ridge, Gul Root and Jeannette Howe, the senior Department of Health pharmacy team. Ten years ago such an open interaction would have been little more than a pipe dream.

Lord Darzi was challenged for omitting pharmacy from a sample patient pathway (it will be interesting to see if he has corrected this by the time of the next Darzi pharmacy meeting in Manchester), but accepted an invitation to spend some time visiting pharmacies, to see for himself how we help patients and the public and place value on it.

NHS Director of Commissioning Gary Belfield was also challenged about the commissioning environment and the effective exclusion of pharmacy from practice-based commissioning. He agreed to meet pharmacy representatives for more discussion.

There is clearly much work still to do if we are to raise the profession’s profile and influence from the first division to the premier league among health professions. Only then can we maximise our contribution to healthcare.

All of this leads me to believe that, however frustrating the circumstances, pharmacists must continue to engage with the Darzi consultations at local and national levels, and exert the maximum possible influence on the upcoming pharmacy White Paper.

It is pleasing to see the Society working co-operatively with the DoH pharmacy team for the profession’s benefit and starting to give pharmacy the promised “strong, clear voice” at the national political level. More of this please!

Graham Phillips
Member of Council
Royal Pharmaceutical Society

Send your letter to The Editor

Next Topic (Glaucoma)

Back to Top


©The Pharmaceutical Journal